demis hassabis isomorphic - Search News

Order byBest matchMost fresh

Alphabet, ai and Isomorphic

‘Solving All Disease’ Using AI is the Mission of Alphabet’s Isomorphic Labs – Its $600M in Funding Will Help

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical programs, and accelerate disease research.

New York Post on MSN · 3d

Alphabet’s Isomorphic Labs raises $600M in first funding round for AI drug business

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue on its mission to create new drugs and medicines using AI.

TechCrunch on MSN · 3d

Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

3don MSN

Demis Hassabis on Isomorphic’s $600 million raise, AI, and healthcare’s future

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

3d

Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results